Current "state of the art" on dendritic cell-based cancer vaccines in melanoma. Schwarze JK, Geeraerts X, Tuyaerts S, Neyns B, et al. Curr Opin Oncol 2023;35:87-93.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schwarze JK, Geeraerts X, Tuyaerts S, Neyns B, et al. Current "state of the art" on dendritic cell-based cancer vaccines in melanoma. Curr Opin Oncol 2023;35:87-93.
PMID: 36721893